• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS ELECSYS T4 ASSAY; RADIOIMMUNOASSAY, TOTAL THYROXINE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS ELECSYS T4 ASSAY; RADIOIMMUNOASSAY, TOTAL THYROXINE Back to Search Results
Catalog Number 07027885190
Device Problem High Test Results (2457)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 12/09/2020
Event Type  malfunction  
Manufacturer Narrative
The customer performed interference testing with a heterophilic blocking tube and polyethylene glycol (peg) precipitation.The investigation is ongoing.
 
Event Description
The initial reporter questioned results not meeting the clinical picture for 1 patient tested for elecsys t3 (t3), elecsys t4 (t4), elecsys pth (pth), elecsys ft3 iii (ft3 iii) and elecsys t4 (t4) on 2 cobas e801 modules.This medwatch will cover t4.Refer to medwatch with patient identifier (b)(6) for information on the pth results, medwatch with patient identifier (b)(6) for information on the t3 results and medwatch with patient identifier (b)(6) for information on the ft3 iii results.Data was provided for 2 samples from the patient obtained on (b)(6) 2020 and (b)(6) 2020.The e801 module serial numbers were(b)(4).The customer suspects an antibody interference.The patients pth results are low with no symptoms of hypoparathyroidism or issues with ca, po4 or vitamin d results.The patients t3, ft3 iii and t4 results are elevated with no symptoms of hyperthyroidism and the patients tsh and ft4 ii results were normal.
 
Manufacturer Narrative
Two samples from the patient were submitted for investigation where an interfering factor against streptavidin was confirmed.This interference caused the high ft3 iii, t4 and t3 results and the low pth results.This interference is addressed in product labeling: "in rare cases, interference due to extremely high titers of antibodies to analyte-specific antibodies, streptavidin or ruthenium can occur.These effects are minimized by suitable test design." the investigation did not identify a product problem.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELECSYS T4 ASSAY
Type of Device
RADIOIMMUNOASSAY, TOTAL THYROXINE
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
MDR Report Key11171286
MDR Text Key227017804
Report Number1823260-2021-00171
Device Sequence Number1
Product Code CDX
Combination Product (y/n)N
PMA/PMN Number
K961490
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,user faci
Type of Report Initial,Followup
Report Date 04/16/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date04/30/2021
Device Catalogue Number07027885190
Device Lot Number44937601
Was Device Available for Evaluation? Yes
Initial Date Manufacturer Received 12/21/2020
Initial Date FDA Received01/14/2021
Supplement Dates Manufacturer Received12/21/2020
Supplement Dates FDA Received04/16/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
CYCLOBENZAPRINE; VITAMIN D3
Patient Age33 YR
-
-